Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Masimo Preliminary Q2 2024 Revenue Expected To Be ~$496M

Author: Benzinga Newsdesk | July 09, 2024 09:06am

Masimo Corporation (NASDAQ:MASI) today announced preliminary revenue and select financial results for the second quarter ended June 29, 2024.

Preliminary Second Quarter 2024 Revenue and Select Financial Results:

  • Consolidated revenue is expected to be approximately $496 million, representing 9% growth on a reported basis and 10% growth on a constant currency basis;
  • Healthcare revenue is expected to be approximately $344 million, representing 22% growth on a reported basis and 23% growth on a constant currency basis;
  • Non-healthcare revenue is expected to be approximately $152 million, representing a 13% decline on a reported basis and an 11% decline on a constant currency basis;
  • Incremental value of new healthcare contracts(1) is expected to be approximately $134 million; and
    • Driver shipments(2) are expected to be approximately 58 thousand.

Posted In: MASI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist